版本:
中国

BRIEF-Theratechnologies partner Taimed submits biologics license application for Ibalizumab

May 3 Theratechnologies Inc

* Theratechnologies partner submits biologics license application for HIV Monoclonal Antibody and long-acting investigational antiretroviral Ibalizumab

* Taimed has requested priority review for application Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐